Reasons To Buy, Hold Or Sell AstraZeneca plc

Here’s why investors have differing opinions on AstraZeneca plc (LON: AZN).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

AstraZeneca (LSE: AZN) (NYSE: AZN.US) is one of the largest companies in the FTSE 100 and many private investors have differing opinions about the pharmaceutical group and its prospects.

So here’s a quick rundown of some reasons why you may wish to buy, sell or simply hold on to the company’s shares.


AstraZeneca has been in the doldrums for some time now, and its share price has significantly underperformed the FTSE 100 over the past year. So why would anyone want to buy it?

Well, over the same past 12 months, new leader Pascal Soriot has made some encouraging changes, including a major shake-up of the group’s senior management, and a new global strategy that’s clearly focused on R&D.

And he has embarked on some strategic acquisitions of companies with treatments that are well advanced in clinical trials, to provide a further boost to the product pipeline.

Bringing new pharmaceutical treatments to market is a marathon not a sprint, so it’ll take time for everything to pay off.  But if and when it does, AstraZeneca should start to provide patient investors with some decent capital growth.


Even if AstraZeneca’s share price isn’t likely to surge in the near future, many people will be content to hold the shares just for their 6% yield — far more than you could get if you put your money into a savings account.

Of course, the company will need to maintain its dividend for it to remain attractive, but so long as earnings don’t drop significantly the blue chip should be able to sustain the payout, even if the company is not able to actually increase it. 


If you do own shares in AstraZeneca you might well be asking yourself why you’d want to continue to hold a company that faces such an uphill and long-term struggle ahead of it? And it’s a struggle that AstraZeneca is far from certain of winning.

And why would you want to own a company whose revenue in 2018 might be 25% lower than it was last year, assuming recent consensus analyst forecasts prove to be accurate.

Even if, as AstraZeneca has said, it believes it can “significantly exceed” the consensus, its revenue is still likely to remain relatively disappointing for a long time to come, which could threaten both its capital growth and ability to maintain its dividend. Surely there are better companies in which invest?

Top tips

If you’re looking for some high-quality investment opportunities, you should definitely the Motley Fool’s special report , “5 Shares To Retire On“.

This exclusive report features five top-quality shares — companies that have an outstanding record of providing reliable shareholder returns — selected by our team of top share-pickers here at the Motley Fool.

Get your FREE copy now.

> Jon does not own any share mentioned in this article.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Company Comment

Hand of person putting wood cube block with word VALUE on wooden table
Company Comment

Value has been building behind the Diageo share price

Despite the business growing, the Diageo share price first reached its current level just over 19 months ago and hasn't…

Read more »

Older couple walking in park
Investing Articles

5 stocks to buy for high and rising dividend income

I can see a host of shares to buy on the FTSE 100 offering me exceptional levels of income. Here…

Read more »

Young mixed-race woman looking out of the window with a look of consternation on her face
Investing Articles

I don’t care if FTSE 100 shares fall further, I’m buying them today

I'm happy to go shopping for FTSE 100 shares today, even though I accept that they could have further to…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

Rolls-Royce shares are down 18% in a month and I’m finally going to buy them

Investors who bought Rolls-Royce shares have been repeatedly disappointed, but I'm willing to take a chance on them before they…

Read more »

Storytelling image of a multiethnic senior couple in love - Elderly married couple dating outdoors, love emotions and feelings
Investing Articles

How I’d invest £10k in a Stocks and Shares ISA today

Now looks like a good time to buy cheap FTSE 100 shares inside a Stocks and Shares ISA. These are…

Read more »

Black father holding daughter in a field of cows
Investing Articles

Today’s financial crisis is the perfect moment to buy cheap shares

I'm building a portfolio of FTSE 100 stocks by purchasing cheap shares whenever I see an opportunity. There's a good…

Read more »

Long-term vs short-term investing concept on a staircase
Investing Articles

I’d buy Tesco shares in October to bag their 5.4% yield 

Tesco shares have fallen lately but I think this makes them attractively valued for a dividend stock I would aim…

Read more »

Young mixed-race woman looking out of the window with a look of consternation on her face
Investing Articles

I would do anything to hold Diageo in my portfolio (but I won’t do that)

Diageo is one of my favourite stocks on the entire FTSE 100 and I'd love to hold it, but one…

Read more »